- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Telitacicept 160mg
Total 1485 results
-
LG ChemCompleted
-
HK inno.N CorporationCompletedNon-erosive Reflux DiseaseKorea, Republic of
-
Bastyr UniversityMichael J. Fox Foundation for Parkinson's ResearchCompletedParkinson's DiseaseUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingCancer | Metastatic | Breast | Triple Negative | Disseminated Tumor CellUnited States
-
Fundacion Clinic per a la Recerca BiomédicaActive, not recruiting
-
Zhejiang Genfleet Therapeutics Co., Ltd.Completed
-
Chong Kun Dang PharmaceuticalCompletedHealthy VolunteersKorea, Republic of
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Spain, United Kingdom, United States, France
-
University of PatrasCompletedST Elevation Myocardial Infarction | Fibrinolysis | P2Y12 InhibitorGreece
-
Yokohama City UniversityRecruiting
-
Imuneks Farma ilac San. Tic. A.S.TC Erciyes UniversityCompleted
-
Padagis LLCCompleted
-
Lee's Pharmaceutical LimitedCompletedPharmacokinetic and Pharmacodynamic Profile of TecarfarinHong Kong
-
Daewon Pharmaceutical Co., Ltd.CompletedHypercholesterolemia, DyslipidemiaKorea, Republic of
-
Helixmith Co., Ltd.Completed
-
The Affiliated Hospital of Qingdao UniversityRecruiting
-
Genzyme, a Sanofi CompanyActive, not recruitingTo Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid CancerThyroid CancerUnited States, Italy, Poland, Russian Federation, United Kingdom, Netherlands, Israel, Czechia, India
-
Indiana UniversityEli Lilly and CompanyTerminated
-
Quadram Institute BioscienceBiotechnology and Biological Sciences Research Council; The Danish Council...Completed
-
GL Pharm Tech CorporationCompletedHealthyKorea, Republic of
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyDaiichi Sankyo GermanyCompleted
-
9 Meters Biopharma, Inc.TerminatedShort Bowel SyndromeUnited States
-
Chung Shan Medical UniversityGolden Biotechnology CorporationTerminated
-
The Netherlands Cancer InstituteCompleted
-
Protgen LtdUnknownPancreatic CancerChina
-
Seoul National University Bundang HospitalRecruitingDiabetes Type 2Korea, Republic of
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; Eastern Cooperative Oncology Group and other collaboratorsCompletedBrain and Central Nervous System TumorsUnited States
-
Daiichi Sankyo, Inc.Completed
-
Cheng-Chung WeiGolden Biotechnology CorporationUnknownChronic Hepatitis BTaiwan
-
OrthoTrophix, IncCompleted
-
PfizerCompleted
-
Medicines for Malaria VentureRichmond Pharmacology LimitedCompleted
-
Huahui HealthRecruitingChronic Hepatitis Delta Virus InfectionChina
-
PfizerCompletedBiological AvailabilityUnited States
-
CephalonCompleted
-
Supernus Pharmaceuticals, Inc.RecruitingAttention-Deficit/Hyperactivity DisorderUnited States
-
University of Colorado, DenverActive, not recruitingAutism Spectrum DisorderUnited States
-
Molecular Research Center, Inc.Harrison Clinical Research; Camargo Pharmaceutical Services; Clin Data Services; BARC Global Central Laboratory and other collaboratorsUnknownRheumatoid ArthritisUnited States
-
Shanghai Pharmaceuticals Holding Co., LtdCompleted
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis InfectionUnited States
-
University of FloridaCompletedCoronary Artery Disease | Acute Coronary SyndromeUnited States
-
AllerganEnrolling by invitationIrritable Bowel SyndromeUnited States
-
Bacainn Therapeutics, Inc.CompletedHealthy VolunteersUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedADVANCED HEPATOCELLULAR CARCINOMA (HCC)United States
-
GlaxoSmithKlineCompletedBone Marrow TransplantationUnited States
-
Genzyme, a Sanofi CompanyCompleted
-
Seoul National University Bundang HospitalPfizerUnknownProstate CancerKorea, Republic of
-
Bright Future Pharmaceuticals Factory O/B Bright...Chinese University of Hong KongUnknown
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus Type 2Korea, Republic of